Evaluate Bioequivalence of Micafungin (50mg/Vial)

NCT05496725 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Invasive Candidiasis

Interventions

DRUG: Micafungin

Sponsor

Yung Shin Pharm. Ind. Co., Ltd.